The Pegasus Review: UCF
Undergraduate Research Journal
(URJ)
Volume 11

Issue 2

Article 3

2020

Anatomy and Function of Autonomic Innervation of the Liver
Kennan Negrete
University of Central Florida, kennan.negrete@gmail.com

Part of the Digestive System Commons

Find similar works at: https://stars.library.ucf.edu/urj
University of Central Florida Libraries http://library.ucf.edu
This Article is brought to you for free and open access by the Office of Undergraduate Research at STARS. It has been
accepted for inclusion in The Pegasus Review: UCF Undergraduate Research Journal (URJ) by an authorized editor of
STARS. For more information, please contact STARS@ucf.edu.

Recommended Citation
Negrete, Kennan (2020) "Anatomy and Function of Autonomic Innervation of the Liver," The Pegasus
Review: UCF Undergraduate Research Journal (URJ): Vol. 11 : Iss. 2 , Article 3.
Available at: https://stars.library.ucf.edu/urj/vol11/iss2/3

Negrete: Anatomy and Function of Autonomic Innervation of the Liver

Published
October 24, 2019

Vol. 11.2: 18-31

THE PEGASUS REVIEW:
UNIVERSITY OF CENTRAL FLORIDA
UNDERGRADUATE RESEARCH JOURNAL

Anatomy and Function of Autonomic
Innervation of the Liver
By: Kennan Negrete

Faculty Mentor: Dr. Zixi Cheng

UCF School of Biomedical Sciences

ABSTRACT: The liver is one of the most important regulatory organs, and its extensive influence upon homeostatic
balance is well-documented. However, the role of autonomic innervation in the control and regulation of hepatic
function is poorly understood relative to the other organs of the digestive system. Furthermore, the neuroanatomical
layout of the liver remains an incomplete puzzle with various missing pieces. The scarcity of information concerning
such a critical organ presents an interesting conundrum for the scientific and biomedical communities alike, especially
given the prevalence of liver degeneracy and disease in the modern clinical setting. A more complete understanding of
the precise anatomy of hepatic autonomic innervation, as well as the role it plays in both the normal function and
diseased state of the organ, could aid in the development of novel and improved treatments for various debilitating and
potentially lethal conditions. The purpose of this review is to compile the breadth of knowledge regarding hepatic
autonomic innervation, to discuss the limitations of previous research, and to suggest future directions for a field that
shows great potential for continued advancement.
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INTRODUCTION

BACKGROUND

The liver is a key regulatory organ of both glucose and
lipid metabolism, and various studies have shown that
autonomic innervation plays a role in the regulation of
hepatic function (Akiyoshi, Gonda, & Terada, 1998;
Berthoud, 2004; Kalsbeek et al., 2010; McCuskey, 2004;
Perez-Tilve et al., 2010; Tunderaher, Farr, & Adeli,
2017; Verma, Antony, Ogunnaike, Hoek, & Vadigepalli,
2018; Yi, la Fleur, Fliers, & Kalsbeek, 2010). This
liver-brain axis is under-studied, with many unknowns
regarding its structure, function, and scope (Akiyoshi
et al., 1998; Berthoud, 2004; Kalsbeek et al., 2010;
McCuskey, 2004; Perez-Tilve et al., 2010; Taher et al.,
2017; Verma et al., 2018; Yi et al., 2010). Additionally, in
liver transplant cases, autonomic innervation of hepatic
tissue is significantly reduced, yet the liver continues to
function at a level that deviates only moderately from
normal (Tiniakos, Lee, & Burt, 1996; Yi et al., 2010).
The study of the liver-brain axis is further complicated
by large anatomical differences in nerve distribution
between rodents and higher mammals, particularly in
the parenchyma (Akiyoshi et al., 1998; McCuskey, 2004;
Verma et al., 2018). Despite these obstacles, the study
of the neural map of the liver provides a link between
the organ’s many functions and the influence of the
autonomic nervous system.

The Neural Map of the Rat Liver

This review summarizes knowledge concerning the form
and function of hepatic sensory and motor innervation
acquired over the last five decades. Among the topics
covered are the anatomical neural map of the rodent liver,
which notably lacks intrahepatic ganglia (Berthoud, 2004;
Berthoud and Neuhuber, 2000; Taher et al., 2017), as well
as the influence of the sympathetic and parasympathetic
nervous system upon various metabolic and regulatory
pathways. While substantial evidence implicates the
hypothalamus and autonomic nervous system in various
modifications of liver activity, the precise mechanisms
and interplay of the nervous, endocrine, and hepatic
systems have yet to be fully elucidated. Understanding
of the liver-brain axis is still far from complete, but
technological advances may allow many of the topics
covered here to be revisited and explored in far greater
depth than was previously possible. These advances, in
turn, could potentially lead to the discovery of novel,
neural-based treatments for chronic liver disease.

https://stars.library.ucf.edu/urj/vol11/iss2/3

This discussion begins with analysis of the rat liver, the
most well-studied of the mammalian livers. Although
it provides the most complete picture of the anatomical
layout and physiological role of autonomic innervation
in the hepatic setting, the rat liver is far from the level of
completion seen in the rest of the gastrointestinal tract.
Despite these shortcomings, several major populations
of neurons travelling between the sympathetic and
parasympathetic centers and hepatic tissues have been
identified. Sympathetic afferent innervation travels
through the dorsal root ganglia to the dorsal gray horn of
the spinal cord (Baik et al., 2017; Gardemann, Puschel,
& Jungermann, 1992; Jensen, Alpini, & Glaser, 2013;
Taher et al., 2017; Tiniakos et al., 1996). Vagal afferent
innervation reaches the nucleus of the solitary tract via
the nodose ganglion (Baik et al., 2017; Gardemann et
al., 1992; Jensen et al., 2013; Taher et al., 2017; Tiniakos
et al., 1996). Efferent innervation of the liver is achieved
via two major motor plexuses. The anterior plexus is
located at the hilum alongside the hepatic artery, while
the posterior plexus is found near the portal vein and bile
duct system (Baik et al., 2017; Gardemann et al., 1992;
Jensen et al., 2013; Reilly, McCuskey, & McCuskey,
1978; Taher et al., 2017; Tiniakos et al., 1996). These
plexuses carry parasympathetic fibers originating from
the vagus, especially the dorsal motor nucleus (Baik et
al., 2017; Gardemann et al., 1992; Jensen et al., 2013;
Taher et al., 2017; Tiniakos et al., 1996). Intrahepatic
ganglia, however, have not been found, with only nearby
paraganglia displaying vagal innervation (Berthoud,
2004; Berthoud & Neuhuber, 2000; Taher et al., 2017).
This omission is highly unusual for a major organ and
presents a challenge for future studies that attempt
to locate these missing ganglia. Sympathetic efferent
neurons also innervate the liver, originating in the
intermediolateral spinal column and passing through the
celiac and superior mesenteric prevertebral ganglia (Baik
et al., 2017; Gardemann et al., 1992; Jensen et al., 2013;
Taher et al., 2017). Figure 1, seen below, gives a visual
representation of the known paths between the Central
Nervous System (CNS) and hepatic structures in the rat.
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Figure 1: The origins and pathways of hepatic autonomic innervation in the rat liver.
Vagal afferent innervation reaches the NTS via the
nodose ganglion. Vagal efferent innervation originates in
the paraventricular nucleus (PVN), passes through the
dorsal motor nucleus, and reaches the paraganglia before
terminating primarily in the portal triad. Sympathetic
afferents innervate the vessels and bile ducts, carrying
sensory information to the dorsal horn of the spinal cord
through the dorsal root ganglia. Sympathetic efferent
innervation comes from the PVN and synapses in the
celiac and superior mesenteric ganglia. The arcuate
nucleus (ARC) and suprachiasmatic nucleus (SCN)
exert CNS influence over the PVN, impacting both
sympathetic and parasympathetic responses. Intrahepatic
ganglia have not been found (Baik et al., 2017; Berthoud,
2004; Berthoud and Neuhuber, 2000; Gardemann et al.,
1992; Jensen et al., 2013; Reilly, McCuskey & McCuskey,
1978; Taher et al., 2017; Tiniakos et al., 1996).
Afferent Tracing Techniques
Berthoud and others elucidated the afferent autonomic
innervation of the rat liver using various tracing techniques.
Retrograde and anterograde tracing methods have both
been used to discover the origin and termination sites of
vagal afferents (Berthoud, 2004; Kalsbeek et al., 2010).
In the former, both horseradish peroxidase injections of
the common hepatic branch of the vagus and True Blue
injections of the hepatic artery and portal vein revealed

Published by STARS, 2020

fibers extending to the left nodose ganglion (Berthoud,
2004). Additional horseradish peroxidase injections of
the hilum and bile duct regions revealed innervation
in the right nodose ganglion, which is unusual because
these nerves do not connect to the common hepatic
branch (Berthoud, 2004). Anterograde tracing has been
accomplished with DiI injections, but these studies
have revealed that most of the common hepatic branch
descends to innervate other gastrointestinal structures,
such as the duodenum (Berthoud, 2004). Calretinin and
P2X2/X3 vesicular glutamate transporter both show
promise as more specific tracers, but neither have been
extensively applied to the hepatic setting (Berthoud,
2004). Of the little innervation that reaches the liver
proper, most is found around the bile ducts and portal
triad (Akiyoshi et al., 1998; Berthoud, 2004; Kalsbeek
et al., 2010). Neither technique has thus far revealed
any hepatic vagal innervation in the rat parenchyma
(Akiyoshi et al., 1998; Berthoud, 2004; Kalsbeek et al.,
2010; McCuskey, 2004; Verma et al., 2018).
Researchers have achieved tracing of the spinal dorsal
root ganglionic afferents via the use of calcitoningene-related peptide (CGRP) as a marker (Berthoud,
2004). HRP injections into liver tissue near intrahepatic
bile ducts detected the presence of this substance
primarily around the bile ducts, with very little
innervation of the parenchyma (Berthoud, 2004).
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CGRP immunohistochemistry returned similar results
(Akiyoshi et al., 1998; Berthoud, 2004).
Immunohistochemistry and Variability Between Species
Researchers have also used immunohistochemistry on
other neuropeptide, neurotransmitter, and hormonal
markers to map autonomic innervation in the livers
of both rats and higher mammals. These studies have
revealed more information regarding the innervation of
the rat liver, but also how it differs from the innervation
patterns in humans and other mammals such as the dog or
guinea pig (Akiyoshi et al., 1998). Immunohistochemical
techniques have revealed aminergic, peptidergic, and
cholinergic innervation in the mammalian liver (Akiyoshi
et al., 1998). The former two types of innervation were
traced using various target substances, including tyrosine
hydroxylase (TH), neuropeptide Y (NPY), substance P
(SP), vasoactive intestinal polypeptide (VIP), calcitoningene-related peptide (CGRP), and galanine (GAL)
(Akiyoshi et al., 1998; Burt et al., 1989). These markers
showed the greatest response surrounding the portal
system and bile ducts in the rat liver (Akiyoshi et al.,
1998; Burt et al., 1989; McCuskey, 2004). Nevertheless,
these forms of innervation were also present in all other
species tested, indicating a highly conserved innervation
pattern, at least in the case of these neurons (Akiyoshi et
al., 1998; McCuskey, 2004). Acetylcholinesterase, used
to indicate cholinergic innervation, gave a similar multispecies response (Akiyoshi et al., 1998; McCuskey, 2004).
Higher mammals displayed TH, NPY, and SP
innervation in the parenchyma of the liver, which is
conspicuously absent in the livers of rats and other
small rodents such as hamsters (Akiyoshi et al., 1998;
Burt et al., 1989; Metz & Forssmann, 1980). Further
confirmation of this trend has been provided by
glyoxylic acid-paraformaldehyde fluorescent microscopy,
especially of the guinea pig liver (Metz & Forssmann,
1980). The tree shrew, a small primate, demonstrates
extensive adrenergic innervation extending out from the
triads and into the lobules themselves (Forssmann & Ito,
1977). Researchers have theorized that this additional
sympathetic innervation contributes to the function
of larger livers (Azanza, Aisa, Junquera, & Castiella,
1989). The innervation itself is mainly found along the
spaces of Disse surrounding the fat storing stellate cells
(Forssmann & Ito, 1977; McCuskey, 2004; Streba, Vere,
Ionescu, Streba, & Rogoveanu, 2014). Further study of
the parenchymal innervation of higher mammals in both
normal and pathological settings is required for a better
understanding of this phenomenon. A promising target
https://stars.library.ucf.edu/urj/vol11/iss2/3

for future immunohistochemical techniques is PGP 9∙5
(Lee, Ahmed, Hines, & Burt, 1992). This is a neuronal
axoplasmic protein expressed by parenchymal nerves and
shows potential for reliable marking (Lee et al., 1992).
Interestingly, in species displaying interlobular
innervation, neural penetration of the parenchyma
occurs very late in development (Kandilis, Papadopoulou,
Koskinas, Sotiropoulos, & Tiniakos, 2015). Unlike
other organs of the gastrointestinal tract, the liver does
not receive innervation from the neural crest (Kandilis
et al., 2015). The liver remains poorly innervated until
near term, with only portal innervation present (Kandilis
et al., 2015). Researchers have speculated that because
the liver is mainly involved in hematopoiesis for much
of its fetal life, the additional regulatory innervation for
metabolic function would be unnecessary (Kandilis et al.,
2015).
In rats and hamsters, portal innervation is believed to be
the primary CNS control mechanism, a trait they share
with less complex vertebrates such as frogs (Akiyoshi
et al., 1998; Azanza et al., 1989; McCuskey, 2004).
Where these small livers lack aminergic innervation in
the parenchyma, gap junctions are found to propagate
the electrical signal throughout the liver lobules (Beckh,
Fuchs, Balle, & Jungermann, 1990; Jensen et al., 2013;
McCuskey, 2004; Verma et al., 2018). Researchers
have speculated that gap junctions and sympathetic
innervation share an inverse relationship (Forssmann
& Ito, 1977; McCuskey, 2004). Gap junctions in the rat
liver consist of six connexin-32 units (Streba et al., 2014).
Evidence for the function of these gap junctions is found
in the propagation of intracellular Ca2+ responses, which
requires non-unidirectional concentration gradients and
cellular exchange (Verma et al., 2018). Ca2+ is vital for
many functions of the liver, and monitoring of these
responses in the live rodent model has revealed that they
travel in a wavelike motion from the pericentral region
(PC) region of the liver lobule to the periportal region
(PP) (Verma et al., 2018). The fact that this propagation
is opposite the blood flow of the liver suggests that there
is zonation, or organized differences in cell signaling,
among hepatocytes (Sluka et al., 2016; Verma et al.,
2018). This zonation, however, is under-studied and not
yet fully understood (Verma et al., 2018).
Challenges with Denervation Studies
While structural mapping of the rat liver has produced
both successes and challenges, functional mapping of the

www.URJ.ucf.edu

21

4

Negrete: Anatomy and Function of Autonomic Innervation of the Liver

THE PEGASUS REVIEW:

11.2: 18-31

UNIVERSITY OF CENTRAL FLORIDA
UNDERGRADUATE RESEARCH JOURNAL

liver may prove even more puzzling. The issues primarily
arise from the close association of hepatic innervation
to that of other areas of the gastrointestinal tract, as
well as the difficulty in differentiating between varieties
of hepatic afferents and efferents (Berthoud, 2004;
Yi et al., 2010). Selective vagotomies, for example, are
nearly impossible because the common hepatic branch
of the vagus also innervates the duodenum, and any
physiological changes that occur cannot necessarily be
isolated to a hepatic cause (Berthoud, 2004). The use
of this technique is therefore limited in reliability, but
has been proven effective in the study of sympathetic
efferent using toluidine blue labelling and pseudorabies
virus (Berthoud, 2004). Selective vagal deafferentation
and defferentation are also impractical methods in that
the two types of fibers are extremely difficult, if not
impossible, to separate. (Berthoud, 2004; Yi et al., 2010).
Most afferent fibers elsewhere in the body are reliably
denervated by treatment with capsaicin, which binds
vanilloid receptors and triggers apoptosis (Berthoud,
2004). Hepatic vagal afferents, however, do not always
respond to capsaicin treatment and thus there is no
way of knowing if the deafferentation procedure was
successful (Berthoud, 2004; Yi et al., 2010).
Selective sympathectomies and spinal deafferentation
share similar issues, especially unwanted damage to
nearby vagal pathways (Berthoud, 2004; Yi et al.,
2010). Capsaicin is again an unreliable treatment, as
spinal afferents run alongside other unrelated neurons
in their journey to the dorsal root ganglia (Berthoud,
2004). Therefore, the effects of a supposed “spinal
deafferentation” could be attributed to various other
forms of neural damage and separate effector organ
pathways. As previously mentioned, some successful
studies of sympathetic innervation were carried out with
toluidine blue and pseudorabies virus, but since only
one such procedure has been performed successfully, the
applications are extremely limited in scope (Berthoud,
2004).
In advanced species, interlobular innervation has been
targeted with 6-OH dopamine (Burt et al., 1989;
Forssmann & Ito, 1977). However, this technique is as
unreliable as its counterparts, because it does not degrade
all nerve fibers in the parenchyma, with only some fibers
breaking down to myelin bodies (Forssmann & Ito,
1977). Furthermore, the denervation is not permanent,
regenerating within 60-90 days (Forssmann & Ito, 1977).

Published by STARS, 2020

The extreme difficulties in functional mapping of the
hepatic system should be considered when discussing the
specific functions of CNS innervation (Berthoud, 2004;
Kalsbeek et al., 2010). While there is a general agreement
as to the regulatory functions of many pathways, much of
the CNS role in liver function is poorly understood, and
knowledge is still evolving. Until more accurate methods
of isolating liver innervation are discovered, there will
most likely be a good deal of nervous function that
remains under-studied.
The Hypothalamus: The Primary Brain-Liver Integration
Center
The primary integration center of the liver, as with most
organs under autonomic regulation, is the hypothalamus
(Kalsbeek et al., 2010; Taher et al., 2017; Yi et al., 2010).
This key regulatory center of the brain directly influences
both lipid and glucose metabolism (Kalsbeek et al.,
2010; Taher et al., 2017; Yi et al., 2010). The former
process is controlled by the orexigenic and anorexigenic
populations of the arcuate nucleus (ARC) that mediate
very low-density lipoprotein (VLDL) production by
the liver (Taher et al., 2017). The orexigenic populations
secrete two neuropeptides that function antagonistically
to one another (Taher et al., 2017). NPY increases
hepatic VLDL production by stimulating the activity
of stearoyl CoA reductase-1 (SCD-1), adenosine
diphosphate (ADP) ribosylation factor-1 (ARF-1), and
lipin-1, while galanine-like peptide (GALP) increases
lipid metabolism by increasing the expression of the lipid
transporters carnitine palmitoyl transferases (CTPs) I
and II via sympathetic stimulation ( Jensen et al., 2013;
Rojas et al., 2015; Taher et al., 2017). This is an unusual
function for an orexigenic pathway, but its presence allows
the orexigenic center to both up and down-regulate
lipid metabolism (Taher et al., 2017). The anorexigenic
populations secrete pro-opiomelanocortin, the basis of
a key lipid pathway in the liver-brain axis (Perez-Tilve
et al., 2010; Taher et al., 2017). Pro-opiomelanocortin
(POMC) stimulates second-order neurons to produce
melanocortins 3 and 4 (MC3/MC4) (Perez-Tilve et al.,
2010; Taher et al., 2017). Figure 2 provides a simplified
version of the central melanocortin pathway. Blockage
of this pathway reduces lipogenesis and high-density
lipoprotein (HDL) uptake, and if left unchecked can
lead to liver steatosis, the buildup of fat in liver tissue
(Kandilis et al., 2015; Perez-Tilve et al., 2010; Taher et
al., 2017).
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Figure 2: The central melanocortin pathway and the influence of hormones.
This neural pathway is mostly responsible for
anorexigenic regulation of lipid metabolism, although
POMC populations also play a role in glucose
regulation. Anorexigenic neurons in the ARC produce
POMC, which stimulates second order neurons to
produce melanocortins 3 and 4. These peptides promote
lipogenesis and HDL uptake. The hormones ghrelin and
glucagon-like peptide-1 can cross the blood brain barrier
at the median eminence via specialized cells called
tanycytes. These hormones have antagonistic functions,
with glucagon-like peptide-1 stimulating the central
melanocortin pathway and ghrelin serving an inhibitory
function (Coll & Yeo, 2013; Kandilis et al., 2015; PerezTilve et al., 2010; Taher et al., 2017).
Recent studies have shown that hormonal influences on
the melanocortin pathway have a major impact on the
concentration of high-density lipoprotein cholesterol
(HDL-C) in the plasma (Perez-Tilve et al., 2010).
These influences can be both up and down-regulatory,
as indicated by the actions of ghrelin and glucagon-like
peptide-1 (GLP-1) (See Figure 2, above) (Perez-Tilve
et al., 2010). These hormones access the ARC through
the median eminence, a region of the blood-brain barrier
controlled by modified glial cells called tanycytes (Coll
& Yeo, 2013). Ghrelin is an inhibitor of the central
melanocortin pathway, and treatment with ghrelin
leads to increased circulating HDL-C (Perez-Tilve
https://stars.library.ucf.edu/urj/vol11/iss2/3

et al., 2010). Glucagon-like-peptide is antagonistic to
ghrelin and stimulates the central melanocortin pathway,
lowering circulating HDL-C ( Jensen et al., 2013; PerezTilve et al., 2010). These changes in plasma cholesterol
occur without any associated changes in body weight
in the rat model, even if the melanocortin receptors
are destroyed or impaired (Perez-Tilve et al., 2010).
Therefore, this pathway is likely responsible for HDL-C
uptake rather than production (Perez-Tilve et al., 2010).
The hypothalamus is also involved in afferent lipid sensing,
with the ability to reduce hepatic glucose production to
prevent resting hyperglycemia (Pocai, Obici, Schwartz,
& Rossetti, 2005). Central inhibition of fat oxidation
stimulates the NTS and the dorsal motor nucleus to
down-regulate gluconeogenesis and the construction
of the associated enzymes, thereby lowering hepatic
glucose production (Pocai et al., 2005). This pathway
is mediated by ATP-dependent K+ channels (KATP),
and may require an intact hepatic vagus, as severing
this branch leads to resting hyperglycemia (Pocai et
al., 2005). The ARC provides a second hypothalamic
pathway for lipid sensing (Pocai et al., 2005). A decrease
in CTP1 mitochondrial enzyme activity leads to a buildup of long-chain fatty acyl-CoA (LC-CoA) (Pocai et al.,
2005). This build-up signals an abundance of nutrients
that eventually shifts metabolism from carbohydrates to
lipids and reduces hepatic glucose production (Pocai et
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al., 2005), while ARC action is signaled by an increase in
C-Fos expression following CTP1 inhibition (Pocai et
al., 2005). Neither this pathway nor the NTS mechanism
seems to require vagal afferents to function, and KATP
channels can be stimulated hormonally by leptin and
insulin (Pocai et al., 2005).
The role of the hypothalamus in hepatic glucose
metabolism is closely tied to its larger role in the
circadian rhythms of the body, which are controlled by
the suprachiasmatic nucleus (SCN) ( Jensen et al., 2013;
Kalsbeek et al., 2010). This hypothalamic center has
projections to both the sympathetic and parasympathetic
periventricular nucleus (PVN), the integrating center
responsible for CNS-mediated glucose regulation
(Kalsbeek et al., 2010). The neuronal signals from the
PVN take the form of various neuroendocrine and
neuropeptide secretions (Kalsbeek et al., 2010).
Another proposed parasympathetic pathway for glucose
regulation involves POMC, but there is a significant
conflict in the data regarding this function (Kalsbeek
et al., 2010). POMC neurons have been shown to
respond to leptin, insulin, and serotonin (Coll & Yeo,
2013; Smith, 2018). These hormones work in opposition
of NPY to reduce hepatic glucose production. Central
insulin increases hepatic insulin sensitivity to reduce
gluconeogenesis (Coll & Yeo, 2013; Konig, Bulik, &
Holzhutter, 2012; Smith, 2018). Unlike downstream
melanocortin pathways, however, inhibition of this
pathway does lead to obesity (Kalsbeek et al., 2010).
Individuals who lack central insulin and leptin receptors,
as well as those who lack 5-hydroxytryptamine 2C
receptors (5-HT2CRs) for serotonin have an increased
incidence of obesity and hyperphagia (Coll & Yeo,
2013). Disruption of hypoxia-inducible factor (HIF) and
cellular autophagy in POMC populations also leads to
obesity (Coll & Yeo, 2013).
Other hormones and neuropeptides of the hypothalamus
perform functions related to both feeding behavior and
glucose metabolism, but since these are not always
correlated with one another, each is considered a separate
process (Kalsbeek et al., 2010). Orexin, for example, has
ambiguous effects on obesity, but has been shown to
increase hepatic glucose uptake (Kalsbeek et al., 2010).
Melanin-concentrating hormone (MCH), while critical
to the initiation of feeding behavior, does not appear to
have any effect on glucose metabolism (Kalsbeek et al.,
2010). By contrast, pituitary adenylate cyclase activating
peptide (PACAP), when administered to the brain,
Published by STARS, 2020

increases circulating glucose levels and also reduces
feeding behavior (Kalsbeek et al., 2010).This neuropeptide
may have additional effects on the counterregulation of
hypoglycemia and energy storage in the form of white
adipose tissue (Kalsbeek et al., 2010). VIP has broad
effects upon metabolism and feeding that may impact
hepatic function (Kalsbeek et al., 2010).
The final three hypothalamic hormones discussed
below have some glucose-related function, but their
precise impacts and pathways remain ambiguous. The
first is thyrotropin-releasing hormone (TRH), which
can induce hyperglycemia, but its exact mechanism is
unknown (Kalsbeek et al., 2010). Arginine-vasopressin
(AVP) promotes hepatic glucose production via
gluconeogenesis and glycogenolysis, and modifies insulin
and glucagon release (Kalsbeek et al., 2010), but it has
not been shown to directly impact glucose metabolism
(Kalsbeek et al., 2010). This hormone is of interest due
to its secondary effects on lipid metabolism (Kalsbeek et
al., 2010). It can both up and down-regulate lipogenesis
and lipogenolysis, creating a possible direct link between
hypothalamic glucose and lipid metabolism (Kalsbeek
et al., 2010). The final hormone, oxytocin, reduces food
intake (Kalsbeek et al., 2010). An oxytocin-deficient
model animal will become obese, but once again, there
is no direct link between this function and hepatic
glucose metabolism (Kalsbeek et al., 2010). These three
hormones are not alone in ambiguity. In fact, a large
quantity of PVN secretions have functions that remain
unclear (Kalsbeek et al., 2010).
Neuro-endocrine Interplay in Hepatic Regulation
CNS control of hepatic glucose and lipid metabolism
extends beyond the major hypothalamic pathways
to include various endocrine and receptor-mediated
pathways that aid in systemic regulation of circulating
glucose levels and fat storage (Berthoud, 2004; Forssmann
& Ito, 1977; Jensen et al., 2013; Mizuno & Ueno, 2017;
Taher et al., 2017; Yi et al., 2010). Furthermore, these
peripheral pathways appear to function semi-normally
even without much of the liver-brain axis intact, as with
liver transplant patients (Tiniakos et al., 1996; Yi et al.,
2010).
The liver contains various mechanisms for glucose
sensing, neuronal monitoring of circulating glucose via
glucokinase (GK) and glucose transporters (GLUT)
( Jensen et al., 2013; Mizuno & Ueno, 2017; Yi et al.,
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2010). Liver receptor X (LRX) and carbohydrate response
element-binding protein (ChREBP) are intrahepatic
glucose monitors with unknown signaling pathways
that may involve the autonomic nervous system (Yi et
al., 2010). The former controls the secretion of adropin,
which is a paracrine and endocrine mediator of glucose
and lipid metabolism (Yi et al., 2010). Hepatic insulinsensitizing substance (HISS) is secreted by the liver
following parasympathetic stimulation (Kandilis et al.,
2015; Yi et al., 2010). This substance also increases skeletal
muscle glucose uptake (Yi et al., 2010). Parasympathetic
denervation disrupts this pathway and can reduce total
glucose disposal by as much as 50% (Kandilis et al., 2015).
Interestingly, blockage of M3 cholinergic receptors did
not lead to similar effects, indicating that the vagus may
act through alternative pathways as opposed to direct
acetylcholine stimulation (Kandilis et al., 2015). Central
insulin can modify gluconeogenesis outright, though the
mechanism is still largely ambiguous (Kimura et al., 2016).
The pathway is thought to involve the disinhibition of
IL-6 and STAT-3, both of which reduce the expression
of gluconeogenic enzymes (Kimura et al., 2016). IL-6
and STAT-3 are normally inhibited by vagal innervation
of the α7-nicotinic cholinergic receptors (α7-nAchR)
of Kupffer cells (Kimura et al., 2016). Central insulin
detection leads to suppression of the vagus and release of
these factors (Kimura et al., 2016). In obese and insulinresistant individuals, the vagal inhibition is less successful
(Kimura et al., 2016).
The portal vein is primarily responsible for hepatic
glucose sensing and is especially critical in responding
to systemic hypoglycemia ( Jensen et al., 2013; Yi et al.,
2010). As a hypoglycemic state is often the result of
fasting, portal sensors play a key role in initiating a feeding
response ( Jensen et al., 2013; Yi et al., 2010). The portal
response, however, does not appear to reduce food intake
upon its inhibition and is incapable of detecting rapidonset hypoglycemia ( Jensen et al., 2013). A pathway
involving neural-hormonal crosstalk and transcriptional
regulation is simply too slow to respond in such a short
time frame (Konig et al., 2012). Liver transplant patients
have been shown to have a higher prevalence of systemic
hypoglycemia due to a reduced counterregulatory portal
response ( Jensen et al., 2013).
Lipid-sensing is another key function of the alternative
liver pathways and has been shown to work closely
with the gastrointestinal tract to maintain an optimal
balance of free fatty acids (FFAs) in the blood ( Jensen
et al., 2013; Mizuno & Ueno, 2017; Taher et al., 2017;
https://stars.library.ucf.edu/urj/vol11/iss2/3

Yi et al., 2010). An increase in FFAs either through diet
or through enhanced lipolysis of abdominal adipose
triggers a response in the hepatic vagus that increases
general satiety, but if the increase in FFAs is too great,
overstimulation can lead to insulin resistance and reduced
insulin clearance (Yi et al., 2010). This pathway is likely
mediated by peroxisome-proliferator-activator receptors
(PPARs) in the liver (Yi et al., 2010). Insulin itself is also
active in hepatic lipid sensing, with centralized insulin
responses leading to decreased VLDL production and
increased hepatic lipid storage, and peripheral insulin
responses having an antagonistic function (Taher et
al., 2017). In addition, insulin is often aided by leptin,
which if deficient can lead to insulin resistance, and
by adipokines, factors secreted by brown adipose tissue
(BAT) (Kandilis et al., 2015; Taher et al., 2017).
In times of energy shortage, the liver can respond by
secreting its own mediator of lipid metabolism, fibroblast
growth factor-21 (FGF-21) (Berthoud, Munzberg,
& Morrison, 2017; Clemmensen et al., 2017; Coll
& Yeo, 2013). This hormone increases fat oxidation
and ketogenesis to produce energy during crisis.
This hormone also responds to glucagon and GLP-1
stimulation (Clemmensen et al., 2017).
Various other endocrine inputs can stimulate the
hepatic vagus or spinal afferents. Generally, the vagus
acts in satiety and promotes gluconeogenesis, while the
spinal nerves act in scarcity and promote glycogenolysis
( Jensen et al., 2013; Streba et al., 2014; Yi et al., 2010).
Interleukin-1, for example, is a cytokine that reduces
feeding behavior during illness and acts through hepatic
vagal stimulation (Berthoud, 2004; Jensen et al., 2013; Yi
et al., 2010). Other interleukins may signal hepatocytes
to produce immune proteins ( Jensen et al., 2013; Streba
et al., 2014). Vagal afferents have also been shown to
respond to cholecystokinin (CCK) released from I cells
in the duodenum ( Jensen et al., 2013). This hormone
reduces hepatic glucose production and is inhibited by
a high-fat diet. While the hypothalamus plays a role
in both pathways due to their endocrine nature, even
a denervated liver can still express these functions (Yi
et al., 2010). In liver transplant patients, for example,
the majority of functions are preserved (Tiniakos et
al., 1996; Yi et al., 2010). Yet it should be noted that
a complete denervation is superior to an imbalance,
and that completely denervated patients have the most
trouble mobilizing large stores of glucose in the case of
a fight-or-flight response (Kandilis et al., 2015; Yi et al.,
2010).
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Liver Innervation and Blood Flow
The influence of the autonomic nervous system upon
hepatic function extends beyond metabolism to include
the regulation of blood flow and solute concentration
(Forssmann & Ito, 1977; Tiniakos et al., 1996). The
liver is a heavily supplied organ, and in the event of an
imbalance, it acts to maintain plasma homeostasis in
response to autonomic innervation. This function makes
the liver an extremely valuable peripheral osmoreceptor.
The well-innervated walls of the hepatic blood vessels
can trigger a pressor reflex in which sympathetic efferent
stimulate the vessels to constrict and raise blood pressure
( Jensen et al., 2013; Streba et al., 2014). This activity is
mediated by afferent osmoreceptors such as transient
receptor channel protein vanilloid 4 (TRPV4), which
senses hypoosmotic environments through changes
in ion current. The pressor reflex is impaired in liver
transplant patients that cannot receive the influx of
norepinephrine from adrenergic innervation ( Jensen et
al., 2013; Kandilis et al., 2015; Mizuno & Ueno, 2017).
Another reflex mediated by hepatic innervation is the
hepatorenal reflex, a form of communication between
the portal vein and the kidneys. The portal vein is wellsuited to sensing changes in plasma ion content because
the concentration of dissolved solutes in the portal vein
is much higher than in systemic circulation ( Jensen et al.,
2013; Mizuno & Ueno, 2017). If the portal vein senses
an increase in the concentration of sodium ions portal
innervation acts to dampen sympathetic stimulation of
the kidneys. This innervation leads to increased Na+
excretion and restores ionic balance ( Jensen et al., 2013).
The large amount of blood funneled into the liver also
makes the liver a key target in the case of hemorrhage.
When a large amount of blood is lost from circulation,
the body turns to the vast blood supply of the liver as
a counterregulatory mechanism (Gardemann et al.,
1992; Jensen et al., 2013). Sympathetic innervation
of the hepatic artery and its branches stimulates
vasoconstriction, reducing blood flow to the liver in
times of crisis (Beckh et al., 1990; Gardemann et al.,
1992; Jensen et al., 2013; Mizuno & Ueno, 2017). This
process is highly dependent upon endothelin, with TLA
and TLB1 receptors inducing the contraction of the
smooth muscle (Streba et al., 2014). Higher mammals
possessing aminergic innervation of the spaces of disse
also experience contraction of the sinusoids (Burt et
al., 1989; Gardemann et al., 1992; Jensen et al., 2013;
Mizuno & Ueno, 2017). This process expels blood
into the systemic circulation to restore blood volume
Published by STARS, 2020

and is mediated by catecholamines and substance P
(Gardemann et al., 1992; Jensen et al., 2013). When
the crisis has passed, vagal innervation works to relax
the sinusoids (Gardemann et al., 1992; Jensen et al.,
2013). Acetylcholine and vasoactive intestinal peptide
induce relaxation and allow the liver to resume its
normal filtration of the blood (Gardemann et al., 1992;
Jensen et al., 2013; Streba et al., 2014). Liver transplant
patients, who lack these regulatory controls, are at high
risk for hypovolemic shock due to reduced portal flow
(Gardemann et al., 1992; Jensen et al., 2013; Kandilis
et al., 2015). In fact, application of norepinephrine and
epinephrine to a denervated liver results in an arterial
buffer phenomenon, where portal flow is lost and hepatic
artery flow increases (Gardemann et al., 1992; Jensen et
al., 2013; Kandilis et al., 2015).
Liver Innervation and Bile Secretion
The liver’s network of bile ducts is innervated in
many species, although usually in conjunction with
nearby blood vessels. Therefore, hepatic autonomic
innervation has an extensive impact on the flow and
secretion of bile through the biliary system. Specialized
epithelial cells, known as cholangiocytes, modify bile
through the absorbance and secretion of bile salts and
bicarbonate. These, in turn, are under sympathetic and
parasympathetic control (Baik et al., 2017; Mizuno
& Ueno, 2017). Cholinergic action is mediated by
M3 cholinergic receptors on the cholangiocytes, and
stimulation of these induces cholangiocyte proliferation
and an increase in secretion of bicarbonate (Mizuno &
Ueno, 2017).
Cholangiocytes also possess α and β adrenergic
innervation, with the α-1 and α-2 receptors functioning
antagonistically to one another (Mizuno & Ueno, 2017).
The α1-adrenergic receptor pathway normally decreases
ductal secretion, but this function can be reversed by
exposure to phenylephrine, a factor that also promotes
cholangiocyte proliferation ( Jensen et al., 2013).
By comparison, α2-adrenergic receptor stimulation
down-regulates the Gαq pathway responsible for
aiding phenylephrine-induced proliferation ( Jensen
et al., 2013). The antagonism of these two pathways is
temporarily interrupted in the event of biliary injury,
when both cooperate to increase expression of cyclical
adenosine monophosphate (cAMP) and protein kinase
B (Akt) to hasten the repair process ( Jensen et al., 2013).
In addition to the adrenergic sympathetic pathways, the
cholangiocytes also respond to a dopaminergic pathway

www.URJ.ucf.edu

26

9

The Pegasus Review: UCF Undergraduate Research Journal (URJ), Vol. 11 [2020], Iss. 2, Art. 3

THE PEGASUS REVIEW:

11.2: 18-31

UNIVERSITY OF CENTRAL FLORIDA
UNDERGRADUATE RESEARCH JOURNAL

that functions similarly to α2 stimulation ( Jensen et al.,
2013).
Cirrhotic Livers and Neuronal Regulation of Tissue
Regeneration
The sympathetic nervous system has been shown to be
both beneficial and disruptive to the repair of cirrhotic
liver injury (Baik et al., 2017). Sympathetic innervation
exerts its influence through the regulation of hepatic
stellate cells (HSC) and oval cells (HOC) ( Jensen et
al., 2013). HSCs are normally responsible for producing
extracellular matrix and storing vitamin A ( Jensen et
al., 2013; Streba et al., 2014). However, in the event of
liver damage, these proliferate as myofibroblasts and
synthesize collagen ( Jensen et al., 2013). While this
function itself is not necessarily harmful, a buildup
of collagenous scar tissue can eventually impair liver
function and cause abnormal regrowth, a cycle of
continued damage demonstrated in Figure 3 ( Jensen et
al., 2013; Mizuno & Ueno, 2017). HSCs are stimulated
by aminergic innervation and may also aid their own
proliferation by secreting catecholamines themselves
(Figure 3) ( Jensen et al., 2013).
This activity is responsible for the initial spike in
catecholamines documented soon after liver damage,
even though the growth nodules themselves tend to be

denervated ( Jensen et al., 2013; Kiba, 2002; Lee et al.,
1992; Tiniakos et al., 1996). The proliferation of HSCs
combined with aminergic stimulation blocks the growth
of HOCs, which are necessary for the regeneration of
hepatocytes (Figure 3) ( Jensen et al., 2013; Kandilis et
al., 2015). Much of the abnormal growth seen in cirrhotic
livers is thought to be caused by the impairment of these
cells ( Jensen et al., 2013). Sympathetic stimulation
also tends to exacerbate the damage by reducing blood
supply to the liver ( Jensen et al., 2013; Kiba, 2002). Thus,
inhibition of the hepatic sympathetic fibers may be a
potential treatment for cirrhosis in the future ( Jensen et
al., 2013).
Pathogenesis occurs through a cycle of damage and
sympathetic response. Initial trauma leads to a surge
in catecholamines, which causes the proliferation of
stellate cells and inhibits oval cells. Stellate cells produce
collagenous scar tissue, leading to abnormal regrowth.
Constriction of the hepatic artery leads to further
damage, and the cycle continues. Patients are at risk for
developing hepatocellular carcinoma if abnormal growth
persists (Baik et al., 2017; Jensen et al., 2013; Kandilis et
al., 2015; Kiba, 2002; Mizuno & Ueno, 2017).
The parasympathetic nervous system influences liver
regeneration through the hepatic thymidine kinase
and aspartate transcarbamoylase pathways ( Jensen et

Figure 3: Sympathetic stimulation leads to abnormal regeneration in cirrhotic livers.
https://stars.library.ucf.edu/urj/vol11/iss2/3
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al., 2013). Loss of subdiaphragmatic vagal innervation
impairs liver regeneration, but this connection is
confounded by other factors such as reduced food
intake and impaired gastric emptying (Kiba, 2002).
A ventromediolateral hypothalamic lesion, which
increases vagal activity, was shown to have the opposite
effect, increasing hepatic regeneration (Kiba, 2002). The
hypothalamus plays a role in mediating liver apoptosis.
Though the details of this role are somewhat ambiguous,
the hypothalamus is thought to have an impact on
cholinergic innervation (Kiba, 2002).
Liver innervation may not only be regulatory to tissue
regeneration, but also necessary for it (Mizuno & Ueno,
2017). Studies have shown that regeneration of the rat
liver is possible as long as the fibers of the porta hepatis
remain intact (Kiba, 2002). Furthermore, in observations
of advanced cirrhosis and hepatocellular carcinoma, the
infiltration of sympathetic innervation and subsequent
stimulation of α1 adrenergic receptors on Kupffer cells
were shown to promote carcinogenesis (Huan et al.,
2017). Kupffer cells release Interleukin-6 (IL-6) and
transforming growth factor β (TGF-β), both of which
are associated with poor prognosis in hepatocellular
carcinoma patients (Boilly, Faulkner, Jobling, &
Hondermarck, 2017; Huan et al., 2017). Sympathetic
denervation improved the prognosis significantly, and
evidence from other studies indicates neural-immune
interplay in the generation of tumors (Boilly et al.,
2017; Huan et al., 2017). Carcinogenesis displays many
similarities with epimorphic regeneration of limbs and
organs (Boilly et al., 2017). Both processes require the
invasion of macrophages, induction of inflammation
by interleukins, and secretion of growth factors, all of
which are aided by sympathetic innervation (Boilly et al.,
2017; Streba et al., 2014). In many aggressive cancers,
tumor cells secrete neurotrophic growth factor (NGF)
to promote axonogenesis and the innervation of the
tumor tissue (Boilly et al., 2017). This benefits the cancer
in two ways. First, innervation stimulates β-adrenergic
and muscarinic receptors expressed by cancer cells,
inducing rapid and aggressive proliferation (Boilly et al.,
2017). Second, access to a neural trunk allows cancers to
metastasize (Boilly et al., 2017). Therefore, denervations,
especially sympathetic denervations, are considered new
targets for cancer therapy (Boilly et al., 2017; Huan et
al., 2017). The critical role liver innervation plays in
both normal and abnormal tissue growth cannot be
discounted.

Published by STARS, 2020

Other Liver Diseases and their Impacts
While cirrhosis is a highly prevalent liver condition that
has been shown to have both structural and functional
impacts upon the organ, other maladies of the liver have
also been shown to present alterations in liver neural
structure. Among these are hepatitis B and C (Baik et
al., 2017). Both conditions reduce liver innervation as
well as the production of S100B mRNA (Baik et al.,
2017). S100B is a calcium-binding protein found in
the cytoplasm of glial cells and serves as an indicator
for portal innervation (Baik et al., 2017). An absence of
S100B-coding RNA indicates a loss of innervation, and
this trend has also been reported for liver cirrhosis as well
as hepatocellular carcinoma (Baik et al., 2017; Kandilis
et al., 2015). This observation may seem counterintuitive,
as innervation is critical to the degeneration of these
conditions, and indeed various studies have found that
there is an increase in hepatic innervation present,
but both sides of this debate have reported similar
problems with accurate quantification (Baik et al., 2017).
Regardless of form, the abnormal growth of nodules,
tumors, and other structural features of disease results in
abnormal innervation. As with cirrhosis, fibrotic growth
of the HSCs is speculated to be a contributing factor
to liver denervation in other conditions, but evidence
shows that once mRNA expression is altered, it becomes
independent of further fibrosis (Baik et al., 2017).
DISCUSSION
This paper has offered an overview of the current literature
surrounding the anatomy and physiology of autonomic
innervation of the liver and has explored the interaction
between the CNS and hepatic tissue to maintain
homeostasis and regulate metabolism. However, this
review would be incomplete without an analysis of the
issues that remain unresolved, as well as the directions
future studies may take to answer these questions.
First, it is worth noting that much of the information
contained in this review was drawn from studies that are
many years, even decades old. There thus exists a lack
of recent literature regarding hepatic innervation. The
paucity of information concerning the liver-brain axis
would suggest one of two possibilities: either that limited
progress has been made, or that the discouraging lack of
knowledge regarding the topic has sidelined it in favor
of other targets. In either case, the fact that relatively
little recent literature exists means that much of the
current knowledge surrounding liver innervation is in
dire need of an update. Study of these topics was likely
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limited by the technology of the past, but with modern
advances in microscopy, tissue sectioning, and labelling,
new studies could be undertaken to not only validate the
predecessors but also discover new information. Among
the most important issues to be addressed are the elusive
intrahepatic ganglia. The idea that an organ as large,
complex, and critical as the liver would lack such vital
neural structures seems absurd, yet no such formation
has been found to date (Berthoud, 2004; Berthoud and
Neuhuber, 2000; Taher et al., 2017). An inability to find
a structure is hardly compelling evidence that it is not
present at all, especially given the dated methods used
before. Thus, the search for intrahepatic ganglia must be
continued.
The physiology of liver innervation has more gaps
in the literature than the anatomy of the neurons
themselves. More specifically, the current knowledge
understands “what” sympathetic and vagal stimulation
of hepatic tissue is likely responsible for, but “how” the
mechanisms operate is largely unknown. For example,
there is a suspected parasympathetic pathway of NPY
function, but so far only the sympathetic arm has been
elucidated in appreciable detail (Kalsbeek et al., 2010;
Smith, 2018). TRH is known to induce hyperglycemia,
but the mechanism behind this blood sugar spike is not
available (Kalsbeek et al., 2010). This mechanism could
be neural or endocrine, and involve autonomic pathways
from the CNS, but only further study will be able to say
for certain. Perhaps the strangest and most puzzling
problem of all is how the liver functions without CNS
innervation. Liver transplant patients have hepatic
tissues that operate almost normally (Tiniakos, Lee, &
Burt, 1996; Yi et al., 2010). If the liver-brain axis is as
vital as some data suggest, why are denervated livers able
to perform most of the same actions a normal liver can?
The ambiguity surrounding the anatomy, function, and
necessity of hepatic autonomic innervation makes this
area a vital field of future study.

to be isolated according to type, origin, and secretions.
Chemical and biological agents that specifically target
sympathetic hepatic neurons may be especially important
for treating liver cirrhosis and cancer, since sympathetic
stimulation is partly responsible for the progression
of these diseases (Baik et al., 2017; Huan et al., 2017;
Jensen et al., 2013). Such technologies are within our
capacity to develop and doing so will reveal the location
of intrahepatic ganglia as well as elucidate the various
CNS pathways that are currently incomplete.
CONCLUSION
The connection between the liver and the central
nervous system is a vastly under-studied arena with
various unknown structures, functions, and mechanisms
(Akiyoshi et al., 1998; Berthoud, 2004; Kalsbeek et al.,
2010; McCuskey, 2004; Perez-Tilve et al., 2010; Taher et
al., 2017; Verma et al., 2018; Yi et al., 2010). A large part
of this knowledge gap is due to the inability of previous
technologies to properly isolate and map liver innervation
(Berthoud, 2004; Yi et al., 2010). As biomedical sciences
continue to advance and our understanding of the
neural structure and function of the liver improves, these
questions may be answered, thereby revealing more of
the widespread impact of autonomic hepatic innervation
in both normal physiology and disease states. Such an
under-studied yet critically important organ provides an
exciting frontier for continued research and the potential
for intriguing new discoveries. This paper provides a brief
analysis of past and current data, taking special note of
areas that require a great deal of further study. Revisiting
the issue of autonomic influence upon hepatic function
could prove incredibly useful to both the scientific and
medical community.

If any scientific progress is to be made toward a more
complete understanding of liver innervation, more
powerful, accurate, and thorough screening and
denervation technologies must be brought to bear. Tracers
such as calretinin and P2X2/X3 vesicular glutamate
transporter have potential (Berthoud, 2004), but have
been used to label liver tissue in few, if any, laboratory
trials. Of even greater importance is the need for a
reliable way to obliterate certain populations of hepatic
neurons without harming unrelated nerves. This method
would allow the functions of specific groups of neurons
https://stars.library.ucf.edu/urj/vol11/iss2/3
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